Variation in the Treatment of Children Hospitalized With Antineutrophil Cytoplasmic Antibody –Associated Vasculitis in the US

ConclusionThe treatment of children with severe AAV is shifting from cyclophosphamide to rituximab, and their need for dialysis, mechanical ventilation, and prolonged hospitalization remains common. Use of plasma exchange is highly variable.

Source: Arthritis Care and Research - August 13, 2017 Category: Rheumatology Authors: Karen E. James, Rui Xiao, Peter A. Merkel, Pamela F. Weiss Tags: Original Article Source Type: research